Exelixis (EXEL) Gross Margin (2012 - 2026)
Exelixis (EXEL) recorded quarterly Gross Margin of 96.73% in Q2 2026, up 1.21% quarter-over-quarter from 95.58% in Q1 2026, and up 18.0% on a YoY basis from 81.98% in Q2 2025.
Exelixis (EXEL) Gross Margin (2012 - 2026) Analysis & Trends
Exelixis' Gross Margin history runs 15 years deep, the most recent figure standing at 96.73% for Q2 2026.
- In Q2 2026, Gross Margin rose 18.0% year-over-year to 96.73%; the TTM figure through Apr 2026 stood at 96.44% (down 33.0% YoY), while the FY2026 annual figure was 96.39%, down 9.0% from the prior year.
- Gross Margin was 96.73% for Q2 2026 at Exelixis, up from 95.58% in the prior quarter.
- In the past five years, Gross Margin ranged from a high of 97.23% in Q2 2024 to a low of 95.0% in Q1 2024.
- Historically, Gross Margin has averaged 96.33% across 5 years, with a median of 96.48% in 2025.
- The sharpest annual moves came in 2024 and 2025: Gross Margin sank 150 bps in 2024, then soared 155 bps in 2025.
- A 5-year view of Gross Margin shows it stood at 96.24% in 2022, then dropped by 1 bps to 95.46% in 2023, then grew by 1 bps to 96.79% in 2024, then gained by 0 bps to 96.89% in 2025, then declined by 0 bps to 96.73% in 2026.
- The last three Gross Margin figures came in at 96.73% (Q2 2026), 95.58% (Q1 2026), and 96.89% (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 79.04% |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 86.85% |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | Exelixis | 13.37 Bn | 12.59 Bn | 590.86 Mn | 96.73% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | 96.73% |
| Jan 2, 2026 | 95.58% |
| Oct 3, 2025 | 96.89% |
| Jul 4, 2025 | 96.57% |
| Apr 4, 2025 | 96.55% |
| Jan 3, 2025 | 96.48% |
| Sep 27, 2024 | 96.79% |
| Jun 28, 2024 | 97.23% |
| Mar 29, 2024 | 95.00% |
| Dec 29, 2023 | 95.46% |
| Sep 29, 2023 | 96.02% |
| Jun 30, 2023 | 96.23% |
| Mar 31, 2023 | 96.50% |
| Dec 30, 2022 | 96.24% |
| Sep 30, 2022 | 96.28% |
| Jul 1, 2022 | 96.79% |
| Apr 1, 2022 | 96.29% |
| Oct 1, 2021 | 96.38% |
| Jul 2, 2021 | 96.14% |
| Apr 2, 2021 | 95.12% |